Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors

✍ Scribed by Markman, B.; Tabernero, J.; Krop, I.; Shapiro, G. I.; Siu, L.; Chen, L. C.; Mita, M.; Melendez Cuero, M.; Stutvoet, S.; Birle, D.; Anak, O.; Hackl, W.; Baselga, J.

• Book ID: 118207005
• Publisher: Oxford University Press
• Year: 2012
• Tongue: English
• Weight: 362 KB
• Volume: 23
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mds011